Close

Protagen AG has announced the start of a collaboration with the University of California, San Francisco (UCSF) to utilize Protagen’s SeroTag® technology to investigate the immuno-profiling of prostate cancer patients treated with checkpoint inhibitors and therapeutic vaccines.

Organovo Holdings, Inc announced that the U.S. FDA granted orphan drug designation for the Company’s treatment of alpha-1 antitrypsin deficiency (“A1AT”) with its 3D bioprinted liver therapeutic tissue.

Mount Sinai researchers have identified novel therapeutic targets for metastatic melanoma, according to a study published in Molecular Cell.

Promoting interdisciplinary exchange between science and industry on the topics of regenerative medicine and cell therapy: this is the objective Sartorius will be pursuing by hosting its second Research Xchange Forum on March 20 and 21, 2018, at Sartorius College in Goettingen.

InVitria, a division of Ventria Bioscience, has announced the launch of a new media formulation service at the international BIO-Europe conference in Berlin, Germany. 

Subscribe to our Newsletter
captcha 
Show more
Show less
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok